跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZAFIBRAL TABLET 200 mg - HSA Drug Approval Details
Approvals
/
HSA
/
ZAFIBRAL TABLET 200 mg
Approved
THERAPEUTIC
ZAFIBRAL TABLET 200 mg
MEDOCHEMIE LTD (CENTRAL FACTORY)
🇸🇬 Health Sciences Authority
Approval Date
Oct 8, 1998
Approval ID
dfa504e7c0cfa2d7
Company
MEDOCHEMIE LTD (CENTRAL FACTORY)
Type
Therapeutic
Approval Details
Approval Id
dfa504e7c0cfa2d7
Drug Name
ZAFIBRAL TABLET 200 mg
Product Name
ZAFIBRAL TABLET 200 mg
Approval Number
SIN10217P
Approval Date
1998-10-08
Registrant
MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder
MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C10AB02
Atc Item Name
bezafibrate
Pharma Manufacturer Name
MEDOCHEMIE SINGAPORE PTE. LTD.
Company Detail Path
/organization/medochemie-singapore-pte-ltd
Active Ingredients
BEZAFIBRATE
200 mg
BEZAFIBRATE
200 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 8, 1998
Approval ID
dfa504e7c0cfa2d7
Type
Therapeutic
Back to HSA Approvals